Agreement integrates Clyde Biosciences' human-relevant, CellOPTIQ cardiotoxicity screen for chemical safety assessment ...

New England Biolabs (NEB ®) will present several scientific posters at this week's Society for Laboratory Automation and ...

The research team of Weihong Tan, Xiaohong Fang, and Tao Bing from the Hangzhou Institute of Medical Sciences, Chinese Academy of Sciences, proposed a ...

Increase in prevalence of genetic disorders, shift towards personalized medicine, and surge in demand for forensic DNA ...

According to a new report published by Allied Market Research, titled, "Global Oncology/Cancer Drugs Market by Drug Class Type, Indication, ...

Introduction Mobile health (mHealth) technologies have become increasingly popular for monitoring mental health symptoms and lifestyle behaviours, and are largely reported to be feasible and ...

Objectives This review aimed to provide a pooled estimate of injury incidence and epidemiology in women’s ice hockey.Methods A systematic review and meta-analysis were conducted by searching PubMed ...

A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

Swedish study of 100,000 women found higher rate of early detection, suggesting potential to support radiologists The use of artificial intelligence in breast cancer screening reduces the rate of a ...

Integration of the Xenometrix Ames mutagenicity test modernizes this cornerstone, regulatory-aligned NAM within the ...

The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.